Avanos Medical Inc. (NYSE:AVNS) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET
Company Participants
Scott Galovan – Vice President of Strategy & Corporate Development
Gary Blackford – Chairman
Michael Greiner – Senior VP, CFO & Chief Transformation Officer
Conference Call Participants
Kristen Stewart – CL King
Danny Stauder – Citizens JMP
Operator
Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024.
I would now like to turn the conference over to Scott Galovan, SVP, Strategy and Corporate Development. Please go ahead.
Scott Galovan
Good morning, everyone, and thanks for joining us. It’s my pleasure to welcome you to Avanos’ 2024 Third Quarter Earnings Conference Call.
Speaking first today will be Gary Blackford, Avanos Chair, He’ll be followed by Interim CEO, Michael Greiner. Gary will give an update on our leadership changes before Michael reviews our Third Quarter results, the current business environment and update on our transformation efforts and our fourth quarter 2024 planning assumptions.
We will finish the call with Q&A. A presentation for today’s call is available on the Investors section of our website, avanos.com.
As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, current economic conditions and our industry. No assurance can be given as to future financial results. Actual results could differ materially from those in the forward-looking statements. For more information about forward-looking statements and the risk factors that could influence future results, please see today’s press release and risk factors described in our filings with the SEC.
Additionally, we will be referring to adjusted results and outlook. The press release has information on these adjustments and reconciliations to comparable GAAP financial measures.
Now I’ll
Read the full article here
